Oral valdecoxib and injected parecoxib for acute postoperative pain: a quantitative systematic review

[1]  D. Ormrod,et al.  Valdecoxib , 2020, Drugs.

[2]  Douglas G Altman,et al.  Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses , 2003, BMJ : British Medical Journal.

[3]  M. Kuss,et al.  Efficacy and Safety of Intravenous Parecoxib Sodium in Relieving Acute Postoperative Pain following Gynecologic Laparotomy Surgery , 2002, Anesthesiology.

[4]  R. Moore,et al.  Single-dose rofecoxib for acute postoperative pain in adults: a quantitative systematic review , 2002, BMC anesthesiology.

[5]  S. Talwalker,et al.  The analgesic efficacy of valdecoxib vs. oxycodone/acetaminophen after oral surgery. , 2002, Journal of the American Dental Association.

[6]  K. Verburg,et al.  Valdecoxib Is More Efficacious Than Rofecoxib in Relieving Pain Associated With Oral Surgery , 2002, American journal of therapeutics.

[7]  D. Altman,et al.  Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice , 2002, Journal of health services research & policy.

[8]  K. Steckner,et al.  Intravenous parecoxib sodium foracute pain after orthopedic knee surgery. , 2002, American journal of orthopedics.

[9]  C. Hawkey,et al.  COX-1 and COX-2 inhibitors. , 2001, Best practice & research. Clinical gastroenterology.

[10]  S. Talwalker,et al.  A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain model. , 2001, Clinical therapeutics.

[11]  R. Moore,et al.  Seeking a simple measure of analgesia for mega-trials: is a single global assessment good enough? , 2001, Pain.

[12]  R Day,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[13]  J. Sterne,et al.  Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. , 2000, Journal of clinical epidemiology.

[14]  J. L. Tang,et al.  Misleading funnel plot for detection of bias in meta-analysis. , 2000, Journal of clinical epidemiology.

[15]  D. Gavaghan,et al.  An evaluation of homogeneity tests in meta-analyses in pain using simulations of individual patient data , 2000, Pain.

[16]  R. S. Rogers,et al.  4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. , 2000, Journal of medicinal chemistry.

[17]  P. Wiffen,et al.  Single dose oral ibuprofen and diclofenac for postoperative pain. , 2000, The Cochrane database of systematic reviews.

[18]  Lise,et al.  Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. , 2000, The New England journal of medicine.

[19]  I. Olkin,et al.  Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement , 1999, The Lancet.

[20]  H Perrier,et al.  Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles. , 1999, The Journal of pharmacology and experimental therapeutics.

[21]  P. Wiffen,et al.  Oral aspirin in postoperative pain: a quantitative systematic review , 1999, Pain.

[22]  I. Bjarnason,et al.  COX-2 inhibitors , 1999, The Lancet.

[23]  R. Moore,et al.  An Evidence-Based Resource for Pain Relief , 1998 .

[24]  D. Gavaghan,et al.  Size is everything – large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects , 1998, Pain.

[25]  P. Wiffen,et al.  Comparing analgesic efficacy of non‐steroidal anti‐inflammatory drugs given by different routes in acute and chronic pain: A qualitative systematic review , 1998, Acta anaesthesiologica Scandinavica.

[26]  M. Tramèr,et al.  Impact of covert duplicate publication on meta-analysis: a case study , 1997, BMJ.

[27]  David Gavaghan,et al.  Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: use of pain intensity and visual analogue scales , 1997, Pain.

[28]  D. Gavaghan,et al.  Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics: verification from independent data , 1997, Pain.

[29]  D. Gavaghan,et al.  Deriving dichotomous outcome measures from continuous data in randomised controlled trials of analgesics , 1996, PAIN®.

[30]  A R Jadad,et al.  Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.

[31]  D. Sackett,et al.  The number needed to treat: a clinically useful measure of treatment effect , 1995, BMJ.

[32]  D. Dewitt,et al.  Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. , 1993, The Journal of biological chemistry.

[33]  Douglas G. Altman,et al.  Statistics with confidence: Confidence intervals and statistical guidelines . , 1990 .

[34]  L. M. Anderson.  Statistics with Confidence. Confidence Intervals and Statistical Guidelines , 1989 .

[35]  Juliea Morris,et al.  Statistics in Medicine: Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates , 1988, British medical journal.

[36]  K A L'Abbé,et al.  Meta-analysis in clinical research. , 1987, Annals of internal medicine.

[37]  W. Bretz,et al.  Red Marine Algae Lithothamnion calcareum Supports Dental Enamel Mineralization , 2023, Marine drugs.